AVEO Pharmaceuticals, Inc. (AVEO) was a big mover last session, as the company saw its shares rise by 8% on the day. This gain can be attributable to solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend of the company as the stock is now down 17.8% in the past one-month time frame.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate has remained static. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.
AVEO Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
However, some better-ranked stocks in the healthcare industry include Heska Corporation (HSKA), Forest Laboratories Inc. (FRX) and Jazz Pharmaceuticals plc (JAZZ), all with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AVEO PHARMACEUTICALS INC (AVEO): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
FOREST LABS INC (FRX): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry
- Personal Investing Ideas & Strategies